Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, today announced that ...

Windtree Therapeutics (WINT) announced that Alexandre Mebazaa, MD, one of the world’s recognized leaders in cardiogenic shock, gave a ...

The FDA has opened up the use of Johnson & Johnson’s miniaturized heart pumps to certain pediatric patients, including those ...

The company has collaborated with ACTION to gather real-world data supporting the on-label use of heart pumps.

Danvers: Johnson & Johnson MedTech, has announced that the U.S. Food and Drug Administration (FDA) has expanded the ...

These may range from a mildly symptomatic clinical picture to one characterised by chest pain, heart failure and cardiogenic shock necessitating mechanical circulatory support, as well as ...

Registry data suggest that one third of the patients who would benefit most are not receiving timely defibrillation. In the U.S., in-hospital cardiac arrest occurs about twice as often as out-of ...

Cardiac Failure. Beta-blockers, like RAPIBLYK TM, can cause depression of myocardial contractility and may precipitate heart ...

An electrocardiogram (ECG) is a quick test used to review your heart activity. The winter and holiday season can bring joy, but can also bring stresses and challenges. Explore these 10 tips for ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

4, 2024 — Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection ... The Heart Has Its Own 'Brain' Dec.